Kaempferia parviflora Ethanol Extract, a Peroxisome Proliferator-Activated Receptor Ligand-binding Agonist, Improves Glucose Tolerance and Suppresses Fat Accumulation in Diabetic NSY Mice

被引:20
|
作者
Ochiai, Masaru [1 ]
Takeuchi, Toshiki [2 ]
Nozaki, Tsutomu [3 ]
Ishihara, Ken-o [3 ]
Matsuo, Tatsuhiro [2 ]
机构
[1] Kitasato Univ, Sch Vet Med, 23-35-1 Higashi, Towada, Aomori 0348628, Japan
[2] Kagawa Univ, Fac Agr, Kita Ku, 2393 Ikenobe, Miki, Kagawa 7610795, Japan
[3] BHN Co Ltd, Chiyoda Ku, 1-16 Kandanishiki, Tokyo 1010054, Japan
关键词
fat accumulation; glucose tolerance; Kaempferia parviflora; methoxy flavone; PPAR; ETHYL-ACETATE EXTRACT; TISSUE DISTRIBUTION; INSULIN-RESISTANCE; PANCREATIC LIPASE; PPAR-GAMMA; 5,7-DIMETHOXYFLAVONE; MOUSE; RAT; POLYMETHOXYFLAVONOIDS; PHARMACOKINETICS;
D O I
10.1111/1750-3841.14437
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
This study assessed the effect of Kaempferia parviflora, also known as black ginger (BG), and its ethanol extract (BGE) on peroxisome proliferator-activated receptor (PPAR) agonistic activity, glucose tolerance, fat accumulation, and lipids-induced hypertriglyceridemia in mice. PPAR ligand-binding capacity in vitro and polymethoxy flavone contents were highly observed in organic solvent extracts. In an animal experiment A, male diabetic Nagoya-Shibata-Yasuda mice were divided into five dietary groups and fed each diet for 8 weeks: AIN-93G diet (low-fat [LF] diet), high-fat (HF) diet, HF diet supplemented with 1% BG, HF diet supplemented with 0.19% BGE, and HF diet supplemented with pioglitazone (PPAR agonist, 3 mg/kg/day) as a PPAR agonistic positive control. As determined from glucose and insulin tolerance tests, plasma glucose levels were improved in the BG and BGE groups. The BGE extract suppressed fat accumulation in adipose tissues, liver, and muscles without changing the plasma adiponectin level. In an animal experiment B, in order to investigate the effect of BG and BGE on lipid-induced hypertriglyceridemia, male ddY mice were divided into three test groups: control, BG-administered group (500 mg/kg), and BGE-administered group (100 mg/kg). The plasma triacylglycerol level was not different among the groups during the lipids administration test. These results conclude that the BGE extract containing several kinds of polymethoxy flavones showed PPAR ligand-binding capacity in vitro and prevented obesity and insulin resistance independent of adiponectin secretion in mice.
引用
收藏
页码:339 / 348
页数:10
相关论文
共 50 条
  • [1] A functional peroxisome proliferator-activated receptor-γ ligand-binding domain is not required for adipogenesis
    Walkey, Christopher J.
    Spiegelman, Bruce M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (36) : 24290 - 24294
  • [2] Expression and purification of the ligand-binding domain of peroxisome proliferator-activated receptor alpha (PPARα)
    Mueller, Mathias Q.
    Roth, Christian
    Straeter, Norbert
    Sinz, Andrea
    PROTEIN EXPRESSION AND PURIFICATION, 2008, 62 (02) : 185 - 189
  • [3] New Peroxisome Proliferator-Activated Receptor Agonist (GQ-11) Improves Wound Healing in Diabetic Mice
    Silva, Jacqueline C.
    Pitta, Marina G. R.
    Pitta, Ivan R.
    Koh, Timothy J.
    Abdalla, Dulcineia S. P.
    ADVANCES IN WOUND CARE, 2019, 8 (09) : 417 - 428
  • [4] Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha)
    Gordon, Darren M.
    Hong, Stephen H.
    Kipp, Zachary A.
    Hinds, Terry D., Jr.
    MOLECULES, 2021, 26 (10):
  • [5] Different structures of the two peroxisome proliferator-activated receptor gamma (PPARγ) ligand-binding domains in homodimeric complex with partial agonist, but not full agonist
    Ohashi, Masao
    Oyama, Takuji
    Miyachi, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (13) : 2639 - 2644
  • [6] Overexpression of peroxisome proliferator-activated receptor α in pancreatic β-cells improves glucose tolerance in diet-induced obese mice
    Hogh, K-Lynn N.
    Uy, Christopher E.
    Asadi, Ali
    Baker, Robert K.
    Riedel, Michael J.
    Gray, Sarah L.
    EXPERIMENTAL PHYSIOLOGY, 2013, 98 (02) : 564 - 575
  • [7] MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism
    Seok-Ho Kim
    Shin Hee Hong
    Young-Joon Park
    Jong-Hyuk Sung
    Wonhee Suh
    Kyeong Won Lee
    Kiwon Jung
    Changjin Lim
    Jin-Hee Kim
    Hyoungsu Kim
    Kyong Soo Park
    Sang Gyu Park
    Scientific Reports, 9
  • [8] MD001, a Novel Peroxisome Proliferator-activated Receptor α/γ Agonist, Improves Glucose and Lipid Metabolism
    Kim, Seok-Ho
    Hong, Shin Hee
    Park, Young-Joon
    Sung, Jong-Hyuk
    Suh, Wonhee
    Lee, Kyeong Won
    Jung, Kiwon
    Lim, Changjin
    Kim, Jin-Hee
    Kim, Hyoungsu
    Park, Kyong Soo
    Park, Sang Gyu
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
    Cha, Dae Ryong
    Zhang, Xiaoyan
    Zhang, Yahua
    Wu, Jing
    Su, Dongming
    Han, Jee Young
    Fang, Xuefen
    Yu, Bo
    Breyer, Matthew D.
    Guan, Youfei
    DIABETES, 2007, 56 (08) : 2036 - 2045
  • [10] Conserved amino acids in the ligand-binding and τi domains of the peroxisome proliferator-activated receptor α are necessary for heterodimerization with RXR
    Gorla-Bajszczak, A
    Juge-Aubry, C
    Pernin, A
    Burger, AG
    Meier, CA
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 147 (1-2) : 37 - 47